| Principal Investigator Name: | Charles Henrikson, M.D. | |
| Study Coordinator Name: | Elizabeth Robinson, R.N. | |
| Contact Phone: Study Coordinator | (410) 502 - 0517 | |
| Contact E-mail: Study Coordinator | erobin26@jhmi.edu | |
| Study Short Title: | WBC | |
Study Long Title: | Who Benefits from Cardiac Resynchronization Therapy | |
IRB Number: | WIRB 20061053 | |
| Funding Source: | St. Jude Medical | |
| Summary of Trial: | To determine if an algorithm can be developed based on pre-implant clinical variables to predict responses to CRT therapy. Any patient who receives an FDA approved SJM CRT-D is eligible for enrollment. | |
Inclusions: | New York Heart Association Class III or IV QRS > 130 msec Ejection Fraction < 35% within last 6 months Clinical indication for CRT-D therapy | |
Exclusions: | Unstable angina Patients with an ICD or pacemaker Patients that require revascularization | |
Clinical Trial Site: | Johns Hopkins University 600 N. Wolfe Street, Carnegie 586 Baltimore, MD 21287 | |
| Compensation for Participating? | No | |
| Start Date: | 8/2006 | |
| Anticipated End Date: | 2/2009 |
